Croda has made a ‘major investment’ in Cutitronics, a spin-out company from the University of Strathclyde. The actual sum was not disclosed but is said to represent a ‘significant milestone’ for the start-up, according to a report published by

Cutitronics’ signature product, CutiTron, is an at-home personal care device that assesses skin health and maximises product efficacy by stimulating skin, allowing skin care applications to penetrate into the deeper layers.

“We’re excited to be recognised by Croda and to now be partnering with them. The support from the team at Croda will be invaluable to us as we seek to develop our CutiTron technology, and grow our team,” commented Cutitronics Founder David Heath.

As part of the partnership deal, Croda’s President of Personal Care & North America, Sandra Breene has been appointed to the Cutitronics board as a part-time Non-Executive Officer.